Search

Search results

523 results found

Ask the Experts: Daniel Press, MD

Update on Preventing and Treating Cognitive Symptoms in Parkinson’s Disease By Daniel Press, MD; Chief, BIDMC Division of Cognitive Neurology; Associate Professor of Neurology, Harvard Medical School

Service Preferences

Weekly group sessions are the primary component of both CET and HOPES—the interventions we are comparing in Project SUCCESS. Both Cognitive Enhancement Therapy and Helping Ourselves Perceive & Experience Success leverage the power of social connection to help participants improve social skills and...

Imaging for Risk Assessment

Many decisions that general clinicians need to make daily are based on a risk assessment of different clinical (medical or surgical) interventions relative to the risk of non-intervention. We have a program for developing imaging protocols to better assess risk for patients in several clinical...

Noninvasive MRI Evaluation of Lymphedema

Lymphedema is caused by the accumulation of lymphatic fluid in the interstitial space due to impaired clearance, from congenital causes (primary) or infection, trauma, or medical/surgical treatments (secondary), resulting in (sometimes severe) swelling of the extremities. Visualization and...

Studying Cancer Metabolism In Vivo with Hyperpolarized MRI

Hyperpolarization is a technology for aligning, or polarizing, the nuclear spins in a contrast agent or metabolic tracer. Agents prepared this way can dramatically enhance nuclear magnetization and, as a result, produce MR signals up to 100,000 times stronger versus conventional imaging. This makes...

Quantitative Imaging & Biomarkers

Quantitative imaging is the acquisition, extraction, and characterization of relevant quantifiable features from medical images for use in research and patient care. Standardizing the use of imaging biomarkers in clinical trials reduces the variance inherent across different hardware and software...

Associations of early-life and adult anthropometric measures with the expression of stem cell markers CD44, CD24, and ALDH1A1 in women with benign breast biopsies.

Oh, Hannah, Lusine Yaghjyan, Yujing J. Heng, BA Rosner, Matt B Mahoney, Murthy, GM Baker, and Rulla M. Tamimi. 2024. “Associations of Early-Life and Adult Anthropometric Measures With the Expression of Stem Cell Markers CD44, CD24, and ALDH1A1 in Women With Benign Breast Biopsies.”. Cancer Epidemiol Biomarkers Prev 33 (7): 933-43.

 Valentin BOERO-TEYSSIER

My name is Valentin Boero-Teyssier, and I am a Master's student in bioinformatics at the University of Montreal. I also hold a previous Master's degree in biology, ecology, evolution, and genetics from France. I am passionate about applying computational and analytical tools to solve biological...